Educational Needs & Objectives

KRA 2019 Annual Meeting
Saturday, October 12, 2019
Seelbach Hilton
Louisville, KY
Program Schedule

Educational Needs

As the landscape of healthcare continues to change dramatically, rheumatologists’ understanding of federal reimbursement issues, state policies and changes affecting rheumatologists, and the future of their practice, is growing more significant. As health care continues to evolve, all types of practices — whether they are solo practitioners, employed in multispecialty clinics, or academic based practices — need to understand the changing environment. In addition to the changing healthcare landscape, rheumatologists need to be knowledgeable of the ongoing developments for the management of rheumatic diseases in the areas of systemic lupus erythematosus, spondyloarthritis and psoriatic arthritis in addition to safety of new agents in the field of rheumatology.

Educational Objectives

At the conclusion of the Kentuckiana Rheumatology 2019 Annual Meeting, attendees should be able to:

Update on SLE

Michelle Petri, MD, MPH

  1. Discuss the pathogenesis of lupus.
  2. Review SLE Classification criteria.
  3. Detect the risk of oral steroids.
  4. Discuss clinical trials of new treatments for lupus.

CSRO Advocacy Update

  1. Identify methods that may be utilized by rheumatologists and the medical community to advocate for political action, such as collaborating with provider and patient advocacy organizations and other stakeholders.

SpA/Psoriatic Arthritis: What’s New and What’s Coming

Eric M. Ruderman, MD

  1. Recognize current classification schema for spondyloarthritis and psoriatic arthritis.
  2. Identify current treatment options for psoriatic arthritis.
  3. Identify current treatment options for both radiographic and non-radiographic spondyloarthritis.

Safety of Newer Agents

John J. Cush, MD

  1. Recognize risk factors for serious infectious events.
  2. Identify at-risk patients for tuberculosis (TB) and opportunistic infections.
  3. Interpret the approach to vaccination in rheumatic patients.
  4. Detect immune relate adverse events with checkpoint inhibitor therapy.

State/Local Policy Update

ACR Advocacy Update

  1. Identify legislative trends regarding practice management, private payer reform and medication access of impact to rheumatologists and the medical community at the federal, state and local level.